Virology. Getting rid of a persistent troublemaker to cure hepatitis (Q42224134)

18 October 2017

Virology. Getting rid of a persistent troublemaker to cure hepatitis (English)

1 reference

18 October 2017

0 references

1

1 reference

18 October 2017

2

Charles M Rice

1 reference

PubMed ID

24626921

18 October 2017

language of work or name

English

0 references

publication date

1 March 2014

1 reference

18 October 2017

1 reference

18 October 2017

343

1 reference

18 October 2017

6176

1 reference

18 October 2017

1212-1213

1 reference

Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA.

18 October 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1252186

Inhibition of hepatitis B virus replication by APOBEC3G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1252186

Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1252186

Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1252186

Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1252186

Interferon-β and interferon-λ signaling is not affected by interferon-induced refractoriness to interferon-α in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1252186

IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1252186

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1252186

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1252186

Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues

21 January 2018

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1252186

Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1126/SCIENCE.1252186

Identifiers

DOI

10.1126/SCIENCE.1252186

1 reference

release_dlvxzh7wybfuddbg65crqn2q5a

18 October 2017

0 references

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dlvxzh7wybfuddbg65crqn2q5a

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

24626921

1 reference

PubMed ID

24626921